☆ 4.3 Editorial Material

Proprotein convertase subtilisin/kexin type 9 inhibitors: New insights into cardiovascular atherosclerotic pathophysiology with therapeutic implications

ARCHIVES OF CARDIOVASCULAR DISEASES (2019)

Journal

ARCHIVES OF CARDIOVASCULAR DISEASES

Volume 112, Issue 8-9, Pages 455-458

Publisher

ELSEVIER MASSON, CORPORATION OFFICE

DOI: 10.1016/j.acvd.2019.06.003

Keywords

Familial hypercholesterolaemia; Low-density lipoprotein cholesterol; Low-density lipoprotein receptor; Proprotein convertase subtilisin/kexin type 9; PCSK9 inhibitors

Categories

Cardiac & Cardiovascular Systems

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.